888

TSH BIOPHARM CORPORATION LIMITED

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪2.32 B‬TWD
‪65.35 M‬TWD
‪810.92 M‬TWD
‪15.37 M‬
Beta (1Y)
0.30

About TSH BIOPHARM CORPORATION LIMITED

CEO
Ssu Yuan Yang
Headquarters
Taipei
Founded
2010
ISIN
TW0008432006
FIGI
BBG001QYZ3H1
TSH Biopharm Corp., Ltd. engages in the provision of biotechnology services and sale of pharmaceuticals and chemical drugs. The company was founded on September 1, 2010 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 8432 is 60.3 TWD — it has increased by 2.20% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange TSH BIOPHARM CORPORATION LIMITED stocks are traded under the ticker 8432.
TSH BIOPHARM CORPORATION LIMITED is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
8432 stock is 3.87% volatile and has beta coefficient of 0.30. Check out the list of the most volatile stocks — is TSH BIOPHARM CORPORATION LIMITED there?
Yes, you can track TSH BIOPHARM CORPORATION LIMITED financials in yearly and quarterly reports right on TradingView.
8432 stock has risen by 7.30% compared to the previous week, the month change is a 6.35% rise, over the last year TSH BIOPHARM CORPORATION LIMITED has showed a 34.45% increase.
8432 net income for the last quarter is ‪19.55 M‬ TWD, while the quarter before that showed ‪16.84 M‬ TWD of net income which accounts for 16.12% change. Track more TSH BIOPHARM CORPORATION LIMITED financial stats to get the full picture.
Today TSH BIOPHARM CORPORATION LIMITED has the market capitalization of ‪2.32 B‬, it has increased by 3.09% over the last week.
Yes, 8432 dividends are paid annually. The last dividend per share was 1.60 TWD. As of today, Dividend Yield (TTM)% is 2.65%. Tracking TSH BIOPHARM CORPORATION LIMITED dividends might help you take more informed decisions.
TSH BIOPHARM CORPORATION LIMITED dividend yield was 2.54% in 2023, and payout ratio reached 75.21%. The year before the numbers were 3.36% and 95.87% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 8432 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TSH BIOPHARM CORPORATION LIMITED stock right from TradingView charts — choose your broker and connect to your account.
8432 reached its all-time high on Mar 26, 2012 with the price of 116.1 TWD, and its all-time low was 35.0 TWD and was reached on Aug 25, 2015.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TSH BIOPHARM CORPORATION LIMITED technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TSH BIOPHARM CORPORATION LIMITED stock shows the buy signal. See more of TSH BIOPHARM CORPORATION LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TSH BIOPHARM CORPORATION LIMITED EBITDA is ‪86.20 M‬ TWD, and current EBITDA margin is 10.63%. See more stats in TSH BIOPHARM CORPORATION LIMITED financial statements.